Can FLT3 and NPM1 mutations in myelodysplastic syndromes serve as prognostic biomarkers for progression to acute myeloid leukemia? American Journal of Clinical Pathology
The FDA has granted 510(k) clearance for a device used to reconstitute and administer antihemophilic factor (recombinant) plasma/albumin-free intravenous infusion in patients with hemophilia A. Medscape Medical News
Nilotinib induced significantly higher and faster rates of major molecular response and complete cytogenetic response than imatinib when given as first-line therapy. Medscape Medical News
Ductal adenocarcinoma of the prostate is a rarer than the more common acinar adenocarcinoma, often with a poor outcome. How was it recognized in this patient? Journal of Medical Case Reports